Click to Share

Filter News
Show All Results
News By Country
News By Tag
NLX-112 Remove

August 2020

Public Company News

Business Press Releases

NLX-112 Press Releases

Exclusive News
Topics Locations Industries Dates

By Neurolixis, Inc.
The US Food and Drug Administration (FDA) gave a positive response to Neurolixis' Investigational New Drug (IND) application for NLX-112.
By Neurolixis
Neurolixis launched a collaboration with the GALA® laboratory in Castres, France. GALA® is a platform of the Rapsodee/IMT Mines Albi research facility specialized in developing novel drug formulations.

Page updated every 10 minutes

Like PRLog?
Click to Share